[2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate

C31H48N3O6+ — CID 162813038

IUPAC[2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate
SMILESCC12CCC(=O)C=C1CCC1C2CCC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)NCCCN1CC[NH2+]C1
InChIInChI=1S/C31H47N3O6/c1-29-11-8-22(35)18-21(29)4-5-23-24(29)9-12-30(2)25(23)10-13-31(30,39)26(36)19-40-28(38)7-6-27(37)33-14-3-16-34-17-15-32-20-34/h18,23-25,32,39H,3-17,19-20H2,1-2H3,(H,33,37)/p+1
InChIKeyXVCRFUHDXWFQLN-UHFFFAOYSA-O
MW558.74 g/mol
LogP1.48
Rot. Bonds10

About [2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate

[2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate (PubChem CID 162813038) has the molecular formula C31H48N3O6+ and a molecular weight of 558.74 g/mol. Its IUPAC name is [2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate.

Molecular Properties

Compound Name[2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate
PubChem CID162813038
Molecular FormulaC31H48N3O6+
Molecular Weight558.74 g/mol
Exact Mass558.35
IUPAC Name[2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate
SMILESCC12CCC(=O)C=C1CCC1C2CCC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)NCCCN1CC[NH2+]C1
InChIInChI=1S/C31H47N3O6/c1-29-11-8-22(35)18-21(29)4-5-23-24(29)9-12-30(2)25(23)10-13-31(30,39)26(36)19-40-28(38)7-6-27(37)33-14-3-16-34-17-15-32-20-34/h18,23-25,32,39H,3-17,19-20H2,1-2H3,(H,33,37)/p+1
InChIKeyXVCRFUHDXWFQLN-UHFFFAOYSA-O
XLogP1.48
TPSA129.62 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds10
Heavy Atoms40
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500558.74
LogP ≤ 51.48
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze [2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate?
The IUPAC name of [2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate (CID 162813038) is [2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate.
What is the SMILES notation for [2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate?
The canonical SMILES for [2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate is CC12CCC(=O)C=C1CCC1C2CCC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)NCCCN1CC[NH2+]C1.
What is the InChIKey of [2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate?
The InChIKey is XVCRFUHDXWFQLN-UHFFFAOYSA-O. The full InChI is InChI=1S/C31H47N3O6/c1-29-11-8-22(35)18-21(29)4-5-23-24(29)9-12-30(2)25(23)10-13-31(30,39)26(36)19-40-28(38)7-6-27(37)33-14-3-16-34-17-15-32-20-34/h18,23-25,32,39H,3-17,19-20H2,1-2H3,(H,33,37)/p+1.
What are the key properties of [2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate?
[2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate has a molecular weight of 558.74 g/mol, XLogP of 1.48, 10 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [2-(17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(3-imidazolidin-3-ium-1-ylpropylamino)-4-oxobutanoate is sourced from PubChem (CID 162813038), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).